Biolevate
PrivateLast Round
Series A
Sep 22, 2026
Total Funding Raised
$40.73M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Biolevate is a health-tech company that provides an AI-native knowledge platform designed to accelerate scientific discovery and streamline research and regulatory workflows for life sciences professionals.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Document Management, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biolevate Comparables
Compare Biolevate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sorcero | 85% | |
| AlphaLife Sciences | 84% | |
| Narrativa | 84% |
Biolevate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 22, 2026 | ||||
| Seed | Nov 26, 2024 |
Key People
Founding team and executive leadership
Biolevate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Merck Global Health Innovation Fund | Series A |
| Orange Ventures | Series A |
| EQT Ventures | Series A, Seed |
| Bpifrance | Seed |
| Groupe RAISE | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2026
$34M round led by Groupe RAISE and Orange.
- Aug 21, 2026
Monthly visitors increased 163% MoM, reaching 4.3K.
Biolevate Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access